Aclaris Therapeutics
ACRS
$1.19
Share price
0.00%
Change (1 day)
-85.80%
Change (1 year)
Categories
EPS for Aclaris Therapeutics (ACRS)
EPS in 2023 (TTM): -$1.55
According to Aclaris Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.55. In 2022 the company made an earnings per share (EPS) of -$1.33 an increase over its 2021 EPS that were of -$1.63.
EPS history for Aclaris Therapeutics from 2015 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$1.55 | 16.54% |
| 2022 | -$1.33 | -18.4% |
| 2021 | -$1.63 | 35.83% |
| 2020 | -$1.20 | -69.31% |
| 2019 | -$3.91 | -3.22% |
| 2018 | -$4.04 | 67.63% |
| 2017 | -$2.41 | 6.64% |
| 2016 | -$2.26 | 66.73% |
| 2015 | -$1.36 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$2.18 | 40.65% | 🇺🇸 USA |